Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02913456
What this trial is testing

A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 629
Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT03913234
What this trial is testing

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Who this might be right for
HER2-positive Breast CancerPostmenopausalMetastatic Breast Cancer
Yonsei University 95
Not applicableActive Not RecruitingNCT03870919
What this trial is testing

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients

Who this might be right for
Breast Cancer Stage IVRadiotherapySurgery
UNICANCER 200
Large-scale testing (Phase 3)Study completedNCT00073528
What this trial is testing

Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 1,286
Early research (Phase 1)Ended earlyNCT05489679
What this trial is testing

AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Accutar Biotechnology Inc 6
Early research (Phase 1)Ended earlyNCT02358200
What this trial is testing

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

Who this might be right for
Triple Negative Metastatic Breast CancerBRCA-mutated Solid Tumor
Pamela Munster 23
Not applicableWithdrawnNCT02470819
What this trial is testing

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast TumorAdvanced Gynecologic Cancer
Avera McKennan Hospital & University Health Center
Testing effectiveness (Phase 2)Study completedNCT02129556
What this trial is testing

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT06428396
What this trial is testing

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Who this might be right for
Metastatic Breast Cancer
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)WithdrawnNCT06105008
What this trial is testing

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
RemeGen Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT05735080
What this trial is testing

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Who this might be right for
Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more
Incyclix Bio 150
Not applicableLooking for participantsNCT07455188
What this trial is testing

A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 600
Not applicableStudy completedNCT06873997
What this trial is testing

Real World Study of Bone Metastases in Patients with Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Zhejiang Cancer Hospital 737
Testing effectiveness (Phase 2)Active Not RecruitingNCT03624543
What this trial is testing

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 51
Not applicableStudy completedNCT00735215
What this trial is testing

Faslodex Registry: Fulvestrant in Current Clinical Practice

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 200
Large-scale testing (Phase 3)Ended earlyNCT02054338
What this trial is testing

Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Pierre Fabre Medicament 1,004
Testing effectiveness (Phase 2)WithdrawnNCT00678626
What this trial is testing

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer
Early research (Phase 1)Active Not RecruitingNCT03900884
What this trial is testing

Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

Who this might be right for
Breast Neoplasm Female
Peter MacCallum Cancer Centre, Australia 17
Testing effectiveness (Phase 2)Study completedNCT01997333
What this trial is testing

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

Who this might be right for
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Celldex Therapeutics 327
Next Page